XML 21 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 164,948 $ 58,243
Marketable securities 217,609 3,000
Accounts receivable, net of allowances and reserves of $2,677 and $2,173 as of December 31, 2021 and 2020, respectively 46,117 48,617
Deferred contract acquisition costs, current 11,921 10,528
Prepaid expenses and other current assets 8,467 7,079
Total current assets 449,062 127,467
Property and equipment, net 8,780 9,051
Deferred contract acquisition costs, non-current 20,887 18,753
Other long-term assets 1,760 1,447
Total assets 480,489 156,718
Current liabilities    
Accounts payable 3,123 4,730
Accrued liabilities 18,740 17,439
Deferred revenue 96,225 92,240
Long-term debt, current portion 2,039 2,359
Total current liabilities 120,127 116,768
Long-term debt 1,955 25,727
Other long-term liabilities 3,317 4,022
Total liabilities 125,399 146,517
Commitments and contingencies
Stockholders’ equity (deficit)    
Common stock, $0.0001 par value per share; 500,000,000 and 50,000,000 shares authorized as of December 31, 2021 and 2020, respectively; 47,727,346 and 10,896,137 shares issued and outstanding as of December 31, 2021 and 2020 respectively 5 1
Additional paid-in capital 550,839 27,512
Accumulated deficit (195,519) (171,263)
Accumulated other comprehensive income (235) 94
Total stockholders’ equity (deficit) 355,090 (143,656)
Total liabilities, convertible preferred stock and stockholders’ equity (deficit) 480,489 156,718
Convertible Class A-1 and Class A-2 Preferred Stock    
Current liabilities    
Convertible preferred stock 0 83,857
Redeemable Convertible Class B and Class B-1 Preferred Stock    
Current liabilities    
Convertible preferred stock $ 0 $ 70,000